CRASH (Corticosteroid Randomization after Significant Head Injury Trial): Landmark and Storm Warning
- 1 December 2005
- journal article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 57 (6) , 1300-1302
Abstract
Publication of the first results of the CRASH (Corticosteroid Randomization after Significant Head Injury Trial) trial (11) represents a landmark for head injurKeywords
This publication has 10 references indexed in Scilit:
- Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury—outcomes at 6 monthsThe Lancet, 2005
- Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trialThe Lancet, 2004
- Pharmaceutical industry sponsorship and research outcome and quality: systematic reviewBMJ, 2003
- Clinical Trials in Head InjuryJournal of Neurotrauma, 2002
- Size and quality of randomised controlled trials in head injury: review of published studiesBMJ, 2000
- Risks and Benefits of Preoperative High Dose Methylprednisolone in Surgical PatientsDrug Safety, 2000
- Trials: the next 50 yearsBMJ, 1998
- Corticosteroids in acute traumatic brain injury: systematic review of randomised controlled trialsBMJ, 1997
- Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord InjuryJAMA, 1997
- A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord InjuryNew England Journal of Medicine, 1990